Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: Prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ(2)

Por Garg, Tarun K, Chang, Jason Y
Publicado em 2003

15-deoxy-delta 12, 14-Prostaglandin J(2 )prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress

Por Garg, Tarun K, Chang, Jason Y
Publicado em 2004

Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma

Por Shi, Jumei, Tricot, Guido J., Garg, Tarun K., Malaviarachchi, Priyangi A., Szmania, Susann M., Kellum, Rachel E., Storrie, Brian, Mulder, Arend, Shaughnessy, John D., Barlogie, Bart, van Rhee, Frits
Publicado em 2008

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels

Por Stone, Katie, Woods, Emily, Szmania, Susann M., Stephens, Owen W., Garg, Tarun K., Barlogie, Bart, Shaughnessy, John D., Hall, Brett, Reddy, Manjula, Hoering, Antje, Hansen, Emily, van Rhee, Frits
Publicado em 2013

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

Por Shi, Jumei, Tricot, Guido, Szmania, Susann, Rosen, Nancy, Garg, Tarun K., Malaviarachchi, Priyangi A., Moreno, Amberly, DuPont, Bo, Hsu, Katharine C., Baxter-Lowe, Lee Ann, Cottler-Fox, Michele, Shaughnessy, John D., Barlogie, Bart, van Rhee, Frits
Publicado em 2008

Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma

Por van Rhee, Frits, Szmania, Susann M., Dillon, Myles, van Abbema, Anne M., Li, Xin, Stone, Mary K., Garg, Tarun K, Shi, JuMei, Moreno-Bost, Amberly M., Yun, Rui, Balasa, Balaji, Ganguly, Bishwa, Chao, Debra, Rice, Audi G., Zhan, Fenghuang, Shaughnessy, John D., Barlogie, Bart, Yaccoby, Shmuel, Afar, Daniel E.H.
Publicado em 2009

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

Por Garg, Tarun K., Szmania, Susann M., Khan, Junaid A., Hoering, Antje, Malbrough, Paul A., Moreno-Bost, Amberly, Greenway, Amy D., Lingo, Joshuah D., Li, Xin, Yaccoby, Shmuel, Suva, Larry J., Storrie, Brian, Tricot, Guido, Campana, Dario, Shaughnessy, John D., Nair, Bijay P., Bellamy, William T., Epstein, Joshua, Barlogie, Bart, van Rhee, Frits
Publicado em 2012